Advanced search
Publication Cover
Cancer Management and Research Volume 12, 2020 - Issue
Submit an article Journal homepage
112
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Predicting Prognosis and Adverse Events by Hematologic Markers in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy

Guoxin Cai1 Department of Radiation Oncology, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, People’s Republic of China;2 Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, People’s Republic of China
,
Jinming Yu2 Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, People’s Republic of ChinaCorrespondence[email protected] [email protected]
ORCID Iconhttps://orcid.org/0000-0003-4728-4269
ORCID Icon &
Xue Meng2 Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, People’s Republic of China
Pages 8497-8507 | Published online: 15 Sep 2020

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Yalan Yang, Dao Xin, Huike Wang, Lulu Guan, Xiangrui Meng, Taiying Lu, Xiwen Bai & Feng Wang. (2023) A Novel Predictor of Pathologic Complete Response for Neoadjuvant Immunochemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma. Journal of Inflammation Research 16, pages 1443-1455.
Read now
Tianyan Ding, Cantong Liu, Binliang Huang, Lingyu Chu, Laifeng Wei, Yiwei Lin, Yun Luo, Biao Zhang, Chaoqun Hong, Yiwei Xu & Yuhui Peng. (2021) A Survival Prediction Nomogram for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery. Cancer Management and Research 13, pages 7771-7782.
Read now
Yuan Wang, Jiahua Lyu, Hongyuan Jia, Long Liang, Ling Xiao, Yudi Liu, Xiao Liu, Ke Li, Taiyu Chen, Rongke Zhang, Hangyue Zhang, Chunhan Tang & Tao Li. (2021) Clinical Utility of the Systemic Immune-Inflammation Index for Predicting Survival in Esophageal Squamous Cell Carcinoma after Radical Radiotherapy. Future Oncology 17:20, pages 2647-2657.
Read now

Articles from other publishers (10)

Jifeng Feng, Liang Wang, Xun Yang, Qixun Chen & Xiangdong Cheng. (2023) Pretreatment Pan-Immune-Inflammation Value (PIV) in Predicting Therapeutic Response and Clinical Outcomes of Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology 31:1, pages 272-283.
Crossref
Xiao-Wen Lin, Hao Chen, Xiu-Ying Xie, Can-Tong Liu, Yi-Wei Lin, Yi-Wei Xu, Xin-Jia Wang & Fang-Cai Wu. (2023) Nomogram based on pretreatment hepatic and renal function indicators for survival prediction of locally advanced esophageal squamous cell carcinoma with treatment of neoadjuvant chemoradiotherapy plus surgery. Updates in Surgery.
Crossref
Yuma Obata, Mitsuro Kanda, Dai Shimizu, Hideki Takami, Yoshikuni Inokawa, Norifumi Hattori, Masamichi Hayashi, Chie Tanaka, Goro Nakayama & Yasuhiro Kodera. (2023) The preoperative systemic immune-inflammation index is associated with an unfavorable prognosis for patients undergoing curative resection of esophageal squamous cell carcinoma after neoadjuvant therapy. Surgery Today 53:8, pages 964-972.
Crossref
Wei‐Xiang Qi, Xiaoyan Wang, Chengqiang Li, Shuyan Li, Huan Li, Feifei Xu, Jiayi Chen, Shengguang Zhao & Hecheng Li. (2023) Pretreatment absolute lymphocyte count is an independent predictor for survival outcomes for esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy and pembrolizumab: An analysis from a prospective cohort. Thoracic Cancer 14:17, pages 1556-1566.
Crossref
Jun Yang, Jifang Zheng, Jianjian Qiu, Mengyan Zhang, Lingyun Liu, Zhiping Wang, Qunhao Zheng, Yanyan Liu, Mingqiu Chen & Jiancheng Li. (2023) Systemic Immune-Inflammatory Index, Tumor-Infiltrating Lymphocytes, and Clinical Outcomes in Esophageal Squamous Cell Carcinoma Receiving Concurrent Chemoradiotherapy. Journal of Immunology Research 2023, pages 1-12.
Crossref
Esra KEKİLLİ, Ebru ATASEVER AKKAŞ, Serab UYAR & Emre YEKEDÜZ. (2023) The relationship between systemic immune-inflammation indexes and treatment response in locally advanced esophageal cancer. Anatolian Current Medical Journal 5:1, pages 53-58.
Crossref
Xiaoqi Li, Fei Lv, Ying Wang & Zhenguang Du. (2022) Establishment and validation of nomogram for predicting immuno checkpoint inhibitor related pneumonia. BMC Pulmonary Medicine 22:1.
Crossref
Xiaoqu Li, Shuhao Zhang, Juan Lu, Chao Li & Naibin Li. (2022) The prognostic value of systemic immune-inflammation index in surgical esophageal cancer patients: An updated meta-analysis. Frontiers in Surgery 9.
Crossref
Hua Gao, Laibijiang Wusiman, Bo-Wei Cao, Aireti Wujieke & Wen-Bin Zhang. (2022) The role of preoperative systemic immune-inflammation index in predicting the prognosis of patients with digestive tract cancers: A meta-analysis. Transplant Immunology 73, pages 101613.
Crossref
Qiong He, Yamin Li, Xihong Zhou, Wen Zhou, Chunfang Xia, Ruzhe Zhang, Zhengjie Zhang, Aiyang Hu, Siyin Peng & Jing Li. (2021) The combination of fibrinogen concentrations and the platelet-to-lymphocyte ratio predicts survival in patients with advanced lung adenocarcinoma treated with EGFR-TKIs. Journal of International Medical Research 49:4, pages 030006052110040.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.